Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488

Falling Comet

Download real time

6017.00 -83.00 (-1.36%)

41,345

NSE+BSE Volume

NSE 23 Mar, 2026 9:51 AM (IST)

Patent Expiry

Divi's Labs soars on Friday as Novo Nordisk's patent for Semaglutide is set to expire on Saturday See details

Divi's Laboratories Earnings/Conference Calls

Divi's Laboratories earnings concalls and investor presentations

Is Divi's Laboratories Ltd. worth buying?

756 Votes:

Buy 78.17%

Sell 14.95%

Hold 6.88%

RESEARCH REPORTS

Accumulate SEE REPORTS >

Accumulate SEE REPORTS >